Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

In Vitro Activities of the Benzoquinolizine Fluoroquinolone Levonadifloxacin (WCK 771) and Other Antimicrobial Agents against Mycoplasmas and Ureaplasmas in Humans, Including Isolates with Defined Resistance Mechanisms.

Xue G, Crabb DM, Xiao L, Liu Y, Waites KB.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01348-18. doi: 10.1128/AAC.01348-18. Print 2018 Nov.

PMID:
30104279
2.

Allergic airway sensitization impairs antibacterial IgG antibody responses during bacterial respiratory tract infections.

Totten AH, Xiao L, Luo D, Briles D, Hale JY, Crabb DM, Schoeb TR, Alishlash AS, Waites KB, Atkinson TP.

J Allergy Clin Immunol. 2018 Aug 6. pii: S0091-6749(18)31128-X. doi: 10.1016/j.jaci.2018.07.021. [Epub ahead of print]

PMID:
30092287
3.

Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversity.

Atkinson TP, Centor RM, Xiao L, Wang F, Cui X, Van Der Pol W, Morrow CD, Ratliff AE, Crabb DM, Totten AH, Estrada CA, Faircloth MB, Waites KB.

PLoS One. 2018 Jan 19;13(1):e0189423. doi: 10.1371/journal.pone.0189423. eCollection 2018.

4.

In Vitro Activities of Gepotidacin (GSK2140944) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.

Waites KB, Crabb DM, Xiao L, Duffy LB.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01064-17. doi: 10.1128/AAC.01064-17. Print 2017 Oct.

5.

Mycoplasma hominis Infections Transmitted Through Amniotic Tissue Product.

Novosad SA, Basavaraju SV, Annambhotla P, Mohr M, Halpin AL, Foy L, Chmielewski R, Winchell JM, Benitez AJ, Morrison SS, Johnson T, Crabb DM, Ratliff AE, Waites K, Kuehnert MJ.

Clin Infect Dis. 2017 Oct 1;65(7):1152-1158. doi: 10.1093/cid/cix507.

PMID:
28575162
6.

Sequelae of Donor-derived Mollicutes Transmission in Lung Recipients.

Fernandez R, Chi M, Ison MG, Waites KB, Crabb DM, Ratliff AE, Cajigas H, DeCamp MM, Odell D, Budinger GR, Bharat A.

Am J Respir Crit Care Med. 2017 Mar 1;195(5):687-689. doi: 10.1164/rccm.201607-1377LE. No abstract available.

7.

Shaken or stirred?: Comparison of methods for dispersion of Mycoplasma pneumoniae aggregates for persistence in vivo.

Totten AH, Xiao L, Crabb DM, Ratliff AE, Dybvig K, Waites KB, Atkinson TP.

J Microbiol Methods. 2017 Jan;132:56-62. doi: 10.1016/j.mimet.2016.11.011. Epub 2016 Nov 17.

PMID:
27865739
8.

In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China.

Waites KB, Crabb DM, Duffy LB, Jensen JS, Liu Y, Paukner S.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02008-16. doi: 10.1128/AAC.02008-16. Print 2017 Feb.

9.

In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.

Waites KB, Crabb DM, Liu Y, Duffy LB.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7502-7504. Print 2016 Dec.

10.

Comparative genome analysis of Mycoplasma pneumoniae.

Xiao L, Ptacek T, Osborne JD, Crabb DM, Simmons WL, Lefkowitz EJ, Waites KB, Atkinson TP, Dybvig K.

BMC Genomics. 2015 Aug 16;16:610. doi: 10.1186/s12864-015-1801-0.

11.

Macrolide-Resistant Mycoplasma pneumoniae, United States.

Zheng X, Lee S, Selvarangan R, Qin X, Tang YW, Stiles J, Hong T, Todd K, Ratliff AE, Crabb DM, Xiao L, Atkinson TP, Waites KB.

Emerg Infect Dis. 2015 Aug;21(8):1470-2. doi: 10.3201/eid2108.150273.

12.

Specificity and Strain-Typing Capabilities of Nanorod Array-Surface Enhanced Raman Spectroscopy for Mycoplasma pneumoniae Detection.

Henderson KC, Benitez AJ, Ratliff AE, Crabb DM, Sheppard ES, Winchell JM, Dluhy RA, Waites KB, Atkinson TP, Krause DC.

PLoS One. 2015 Jun 29;10(6):e0131831. doi: 10.1371/journal.pone.0131831. eCollection 2015.

13.

In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas.

Waites KB, Crabb DM, Duffy LB, Huband MD.

Antimicrob Agents Chemother. 2015;59(6):3627-9. doi: 10.1128/AAC.04945-14. Epub 2015 Mar 30.

14.

The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study.

Centor RM, Atkinson TP, Ratliff AE, Xiao L, Crabb DM, Estrada CA, Faircloth MB, Oestreich L, Hatchett J, Khalife W, Waites KB.

Ann Intern Med. 2015 Feb 17;162(4):241-7. doi: 10.7326/M14-1305.

PMID:
25686164
15.

Suppression of antimicrobial peptide expression by ureaplasma species.

Xiao L, Crabb DM, Dai Y, Chen Y, Waites KB, Atkinson TP.

Infect Immun. 2014 Apr;82(4):1657-65. doi: 10.1128/IAI.01231-13. Epub 2014 Feb 3.

16.

Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains.

Paralanov V, Lu J, Duffy LB, Crabb DM, Shrivastava S, Methé BA, Inman J, Yooseph S, Xiao L, Cassell GH, Waites KB, Glass JI.

BMC Microbiol. 2012 May 30;12:88. doi: 10.1186/1471-2180-12-88.

17.

Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.

Xiao L, Crabb DM, Duffy LB, Paralanov V, Glass JI, Waites KB.

Antimicrob Agents Chemother. 2012 May;56(5):2780-3. doi: 10.1128/AAC.06342-11. Epub 2012 Feb 27.

18.

Genotypic characterization of ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis.

Xiao L, Crabb DM, Moser SA, Duffy LB, Glass JI, Paralanov V, Waites KB.

J Clin Microbiol. 2011 Sep;49(9):3325-8. doi: 10.1128/JCM.01235-11. Epub 2011 Jul 27.

19.

Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp.

Xiao L, Crabb DM, Duffy LB, Paralanov V, Glass JI, Hamilos DL, Waites KB.

Int J Antimicrob Agents. 2011 Apr;37(4):377-9. doi: 10.1016/j.ijantimicag.2010.12.012. Epub 2011 Feb 24.

PMID:
21353494
20.

Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.

Waites KB, Crabb DM, Duffy LB.

Antimicrob Agents Chemother. 2009 May;53(5):2139-41. doi: 10.1128/AAC.00090-09. Epub 2009 Mar 2.

21.

Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.

Waites KB, Crabb DM, Duffy LB.

Antimicrob Agents Chemother. 2008 Oct;52(10):3776-8. doi: 10.1128/AAC.00849-08. Epub 2008 Jul 28.

22.
23.

In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominis.

Hilliard NJ, Duffy LB, Crabb DM, Waites KB.

J Microbiol Methods. 2005 Feb;60(2):285-8.

PMID:
15590104
25.

Bactericidal activity of levofloxacin against Mycoplasma pneumoniae.

Duffy LB, Crabb DM, Bing X, Waites KB.

J Antimicrob Chemother. 2003 Sep;52(3):527-8. Epub 2003 Jul 29. No abstract available.

PMID:
12888583
26.

Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.

Waites KB, Crabb DM, Duffy LB.

Int J Antimicrob Agents. 2003 Jun;21(6):574-7.

PMID:
12791472
27.
28.

In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas.

Waites KB, Crabb DM, Duffy LB.

Antimicrob Agents Chemother. 2003 Jan;47(1):39-42.

29.

Evaluation of the Etest for detection of tetracycline resistance in Mycoplasma hominis.

Waites KB, Crabb DM, Duffy LB, Cassell GH.

Diagn Microbiol Infect Dis. 1997 Apr;27(4):117-22.

PMID:
9154407
30.

Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetM confers resistance to tetracycline but not necessarily to doxycycline.

Blanchard A, Crabb DM, Dybvig K, Duffy LB, Cassell GH.

FEMS Microbiol Lett. 1992 Aug 15;74(2-3):277-81.

PMID:
1526460
31.

Comparison of agar versus broth dilution techniques for determining antibiotic susceptibilities of Ureaplasma urealyticum.

Waites KB, Figarola TA, Schmid T, Crabb DM, Duffy LB, Simecka JW.

Diagn Microbiol Infect Dis. 1991 May-Jun;14(3):265-71.

PMID:
1889178
32.

The instep of the foot as a fasciocutaneous island and as a free flap for heel defects.

Morrison WA, Crabb DM, O'Brien BM, Jenkins A.

Plast Reconstr Surg. 1983 Jul;72(1):56-65.

PMID:
6135234

Supplemental Content

Loading ...
Support Center